Lung cancer is the biggest killer of all cancers, responsible for almost 270,000 annual deaths in Europe. Lung cancer screening implementation in Europe has been debated in the scientific community and with politicians at national and European level since long time. Different members of the European Parliament and most experts in the field have agreed that Europe’s health systems need to adapt quickly to allow patients and citizens benefit early diagnosis of lung cancer and thus reducing mortality for this lethal disease.
Beside the assessment of potential economic impact to start implementation, established guidelines to assure effective and safe implementation of lung cancer screening in Europe, are required.
A board of experts has been instituted and endorsed by the European Commission to create such guidelines
- High risk individuals recruitment strategy (How will the target population be reached?)
- Target population definition: age, smoking habit, familiarity, occupational exposure, passive smoking. Population group or risk model. (Which should be the target population?)
- Screening interval: annual, biannual, personalized (How often we must screen individuals?).
- How to select individuals for LC Screening in asbestos exposed subjects?
- Which is the best strategy to identify asbestos exposed high risk people among smokers?
- Are there molecular or radiological risk factors to help selection?